Fierce Pharma Asia—Legend CSO's departure; Takeda's gene therapy deal; Pfizer's India revamp

Legend Biotech's founding chief scientific officer has left the company without a new destination. Takeda has signed another gene therapy deal with Evozyne to work on protein sequences.

Related Keywords

,Fierce Pharma Asia ,Cell Amp Gene Therapy ,Legend Biotech ,Makeda ,Pfizer ,Digital Marketing ,Astrazeneca ,Harbour Biomed ,Rsv ,Dmo ,Asia ,Fierce Pharma Homepage ,Pharma ,